ES2571437T3 - Proceso en un solo reactor para preparar pemetrexed disódico - Google Patents
Proceso en un solo reactor para preparar pemetrexed disódicoInfo
- Publication number
- ES2571437T3 ES2571437T3 ES12826654T ES12826654T ES2571437T3 ES 2571437 T3 ES2571437 T3 ES 2571437T3 ES 12826654 T ES12826654 T ES 12826654T ES 12826654 T ES12826654 T ES 12826654T ES 2571437 T3 ES2571437 T3 ES 2571437T3
- Authority
- ES
- Spain
- Prior art keywords
- salts
- pemetrexed
- single reactor
- pemetrexed disodium
- reactor process
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un proceso eficiente para preparar pemetrexed o sus sales metálicas a partir de ésteres dialquílicos de pemetrexed o sales de los mismos, el cual comprende: a- disolver o suspender un éster dialquílico de pemetrexed o sales del mismo en agua o en una mezcla de agua/alcohol; b- desalinizar e hidrolizar los grupos éster usando hidróxido de metal; c- adicionar sales metálicas hidrosolubles después de ajustar el pH; y d- aislar las sales de pemetrexed de la mezcla mediante filtración.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2011/13223A TR201113223A2 (tr) | 2011-12-29 | 2011-12-29 | Pemetrekset disodyum hazırlanmasına yönelik tek basamaklı işlem. |
PCT/TR2012/000213 WO2013100872A1 (en) | 2011-12-29 | 2012-12-14 | One pot process for preparing pemetrexed disodium |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2571437T3 true ES2571437T3 (es) | 2016-05-25 |
Family
ID=47003823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES12826654T Active ES2571437T3 (es) | 2011-12-29 | 2012-12-14 | Proceso en un solo reactor para preparar pemetrexed disódico |
Country Status (7)
Country | Link |
---|---|
US (1) | US8952153B2 (es) |
EP (1) | EP2797920B1 (es) |
JP (1) | JP5883514B2 (es) |
ES (1) | ES2571437T3 (es) |
RU (1) | RU2577251C2 (es) |
TR (1) | TR201113223A2 (es) |
WO (1) | WO2013100872A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115608309B (zh) * | 2022-10-17 | 2023-10-20 | 连云港贵科药业有限公司 | 一种高纯度培美曲塞二钠的生产方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136101A (en) | 1978-02-03 | 1979-01-23 | American Cyanamid Company | Process for preparing dialkyl (p-aminobenzoyl) glutamates |
EP2322526A1 (en) * | 2006-08-14 | 2011-05-18 | Sicor, Inc. | Crystalline form of pemetrexed diacid and process for the preparation thereof |
CN101417998B (zh) | 2007-10-24 | 2012-10-24 | 重庆医药工业研究院有限责任公司 | 一种培美曲塞盐的纯化方法 |
CA2762190A1 (en) * | 2009-05-28 | 2010-12-02 | Vertex Pharmaceuticals Incorporated | Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase |
TW201118098A (en) | 2009-08-13 | 2011-06-01 | Reddy S Lab Liimited Dr | Processes for preparing pemetrexed |
-
2011
- 2011-12-29 TR TR2011/13223A patent/TR201113223A2/xx unknown
-
2012
- 2012-12-14 JP JP2014550245A patent/JP5883514B2/ja active Active
- 2012-12-14 WO PCT/TR2012/000213 patent/WO2013100872A1/en active Application Filing
- 2012-12-14 RU RU2014111291/04A patent/RU2577251C2/ru active
- 2012-12-14 US US14/352,671 patent/US8952153B2/en active Active
- 2012-12-14 ES ES12826654T patent/ES2571437T3/es active Active
- 2012-12-14 EP EP12826654.1A patent/EP2797920B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20140309420A1 (en) | 2014-10-16 |
EP2797920A1 (en) | 2014-11-05 |
TR201113223A2 (tr) | 2012-06-21 |
EP2797920B1 (en) | 2016-02-24 |
JP5883514B2 (ja) | 2016-03-15 |
WO2013100872A1 (en) | 2013-07-04 |
RU2014111291A (ru) | 2015-09-27 |
RU2577251C2 (ru) | 2016-03-10 |
JP2015503557A (ja) | 2015-02-02 |
US8952153B2 (en) | 2015-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20180152A7 (es) | Pirimidin-2-ilamino-1h-pirazoles útiles como inhibidores de lrrk2 | |
GT201300123A (es) | Sal(es) de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-(2,3-d)-pirimidin-6-carboxilico y procesos para su elaboracion | |
AR088018A1 (es) | Proceso e intermediarios para preparar lapatinib | |
BR112013020513A2 (pt) | adoçante stevia altamente solúvel | |
IN2015DN00909A (es) | ||
GT201000211A (es) | Procesos e intermediarios para la preparación de derivados de acido 5-bifenil-a-il-2-metilpentanoico | |
DOP2014000204A (es) | Compuestos de heterociclilo como inhibidores de mek | |
UY34917A (es) | Inhibidores de la producción de leucotrieno-a4-hidrolasa (lta4h), composiciones farmacéuticas que los contienen y proceso para su preparación | |
CU20140072A7 (es) | Derivados de dihidro-oxazina y dihidro-pirido-oxazina | |
EA201490886A1 (ru) | Переработка биомассы | |
BR112015031233A2 (pt) | métodos de produção de derivados de ácidos graxos omega-hidroxilados | |
MX2016006200A (es) | Metodos para preparar inhibidores de la replicacion de virus de influenza. | |
ECSP11011391A (es) | Métodos y productos intermedios para preparar agentes farmacéuticos | |
CR11853A (es) | Proceso y aparato para extraer biodiesel a partir de algas | |
EA201491149A1 (ru) | Пиразолопиридиновые производные, способы их получения и их терапевтическое применение | |
UA111142C2 (uk) | Одержання заміщених похідних 2-фторакрилової кислоти | |
CY1121055T1 (el) | Μεθοδος για την παρασκευη φορτισμενων διασυνδετων | |
CL2011000296A1 (es) | Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. | |
CL2010001587A1 (es) | Proceso de preparacion de un concentrado de etil esteres de acidos grasos omega-3 que comprende sobre el 80% en peso de dichos esteres en configuracion cis y sus dobles enlaces separados por una unidad metilenica. | |
BR112013030145A2 (pt) | processo para preparação de ácido metacrílico | |
CY1124624T1 (el) | Μητρες οι οποιες περιεχουν εναν τροποποιημενο πολυσακχαριτη | |
ECSP13012548A (es) | Inhibidores de oxadiazol de la producción de leucotrienos. | |
UY34386A (es) | Método para la producción de ácido láctico | |
MX2012001722A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
ES2571437T3 (es) | Proceso en un solo reactor para preparar pemetrexed disódico |